Oops! You got it wrong...
EXPLANATION
✔Correct answer:
Numbness. Adalimumab (Humira) is a tumor necrosis factor (TNF) blocker used to treat various inflammatory conditions, including rheumatoid arthritis. One of the potential serious side effects of Adalimumab is neurological issues, including numbness and tingling. This can indicate demyelinating disorders, such as multiple sclerosis, which have been associated with TNF inhibitors.
Adalimumab works by binding to TNF-alpha, a pro-inflammatory cytokine, and inhibiting its interaction with TNF receptors, thereby reducing inflammation. However, TNF inhibitors can affect the nervous system, potentially leading to demyelination and neurological symptoms.
Think of TNF-alpha as an overactive signal in the body’s immune system, like an alarm that won't stop ringing. Adalimumab helps to turn off this alarm. However, if the body’s wiring (nervous system) is sensitive, turning off the alarm can sometimes cause issues in the wiring, leading to symptoms like numbness.
Nurse Williams should educate the patient about the potential neurological side effects and monitor for any signs of numbness or tingling. If these symptoms occur, it is crucial to notify the healthcare provider immediately for further evaluation and possible adjustment of therapy.
- Educate the patient to report any new or unusual neurological symptoms, such as numbness, tingling, or weakness, immediately.
- Monitor for signs of demyelinating disorders and document any reported symptoms.
- Ensure regular follow-up appointments to assess the patient’s response to the medication and check for side effects.
- Collaborate with the healthcare provider to determine the appropriate course of action if neurological symptoms develop.
✘Incorrect answer options:
Diarrhea. While diarrhea can be a side effect of various medications, it is not a common side effect of Adalimumab. Gastrointestinal symptoms are more commonly associated with other medications used to treat rheumatoid arthritis.
Weight gain. Weight gain is not typically associated with Adalimumab. Side effects more commonly include injection site reactions, infections, and allergic reactions.
Urinary retention. Urinary retention is not a known side effect of Adalimumab. It is more commonly associated with conditions affecting the prostate or medications with anticholinergic effects.
References
- Lehne, R. A., Rosenthal, L. D., & Hernandez, L. M. (2019). Pharmacology for Nursing Care. Elsevier.
- Adams, M. P., Holland, L. N., & Urban, C. Q. (2016). Pharmacology for Nurses: A Pathophysiologic Approach. Pearson.
- van Denderen, J. C., Visman, I. M., & Nurmohamed, M. T. (2009). Safety of TNF inhibitors. Autoimmunity Reviews, 9(1), 100-103.